Protelos Demonstrates Unique Long Term Osteoporotic Fracture Reduction

The results of two landmark studies announced today at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), confirms the evidence based, long-term efficacy of Protelos (strontium ranelate) for the reduction of nonvertebral and vertebral osteoporotic fractures over five years. This is the first time an anti-osteoporotic treatment has demonstrated fracture reduction efficacy after five years of treatment.

Recent Blog Post

beans and lentils

Diet high in protein linked with loss of muscle 

9th March 2023 – By Aaruthy Suthahar Researchers from TwinsUK have found that rather than being protective, high protein intake...

Can use of proton pump inhibitors increase your risk of fractures?

1st February 2023 – By Aaruthy Suthahar Researchers from TwinsUK have found that taking proton pump inhibitors is linked with...

Covid sample

How much of a boost do “booster” COVID-19 jabs give?

26th January 2022 – By Aaruthy Suthahar Scientists have found the “booster” COVID-19 vaccine programme led to a large boost...